Joseph T. Case
YOU?
Author Swipe
View article: An evaluation of selinexor’s clinical trial portfolio: a cross-sectional study
An evaluation of selinexor’s clinical trial portfolio: a cross-sectional study Open
Background: Cancer drug development is a complex and costly process. Selinexor is a drug that received accelerated approval as a new treatment for relapsed or refractory diffuse-large B-cell lymphoma and multiple myeloma. Despite initially…
View article: Endorsement of reporting guidelines and clinical trial registration across urological medical journals: a cross-sectional study
Endorsement of reporting guidelines and clinical trial registration across urological medical journals: a cross-sectional study Open
Introduction Over the years, funding for urologic diseases has witnessed a steady rise, reaching $587 million in 2020 from $541 million in 2018. In parallel, there has been a notable increase in the total number of urology journals from 20…